DC
Diametric Capital Portfolio holdings
AUM
$187M
1-Year Return
38.02%
This Quarter Return
-4.71%
1 Year Return
+38.02%
3 Year Return
+190.23%
5 Year Return
+467.77%
10 Year Return
–
AUM
$84.1M
AUM Growth
-$64M
(-43%)
Cap. Flow
-$60.6M
Cap. Flow
% of AUM
-72.1%
Top 10 Holdings %
Top 10 Hldgs %
25.04%
Holding
410
New
106
Increased
41
Reduced
51
Closed
202
Top Buys
| 1 |
ProShares Ultra VIX Short-Term Futures ETF
UVXY
|
$2.63M |
| 2 |
HES
Hess
HES
|
$1.51M |
| 3 |
ANSS
Ansys
ANSS
|
$1.2M |
| 4 |
NVIDIA
NVDA
|
$1.18M |
| 5 |
Xponential Fitness
XPOF
|
$1.18M |
Top Sells
| 1 |
Harrow
HROW
|
$3.7M |
| 2 |
Boyd Gaming
BYD
|
$3.09M |
| 3 |
Wynn Resorts
WYNN
|
$2.99M |
| 4 |
Cheesecake Factory
CAKE
|
$2.3M |
| 5 |
Pitney Bowes
PBI
|
$2.04M |
Sector Composition
| 1 | Consumer Discretionary | 19.92% |
| 2 | Technology | 13.28% |
| 3 | Healthcare | 13.05% |
| 4 | Energy | 13% |
| 5 | Industrials | 12.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
ClearPoint Neuro
CLPT
$314M
| $136K | 0.16% |
+11,446
| New | +$136K |
|
152
Arcturus Therapeutics
ARCT
$485M
| $134K | 0.16% |
+12,626
| New | +$134K |
|
153
Roivant Sciences
ROIV
$8.82B
| $130K | 0.16% |
+12,921
| New | +$130K |
|
154
INmune Bio
INMB
$51.8M
| $129K | 0.15% |
16,535
-20,164
| -55% | -$157K |
|
155
Magnite
MGNI
$3.54B
| $128K | 0.15% |
11,247
-3,974
| -26% | -$45.3K |
|
156
DHT Holdings
DHT
$2B
| $125K | 0.15% |
11,940
-20,912
| -64% | -$220K |
|
157
Bumble
BMBL
$697M
| $125K | 0.15% |
+28,841
| New | +$125K |
|
158
ICL Group
ICL
$7.85B
| $120K | 0.14% |
21,040
+6,239
| +42% | +$35.5K |
|
159
Magnachip Semiconductor
MX
$107M
| $119K | 0.14% |
+34,610
| New | +$119K |
|
|
LPA
160
Logistic Properties of the Americas
LPA
$200M
| $117K | 0.14% |
13,131
| – | – |
|
161
OptimizeRx
OPRX
$349M
| $115K | 0.14% |
+13,298
| New | +$115K |
|
162
Gran Tierra Energy
GTE
$139M
| $110K | 0.13% |
22,320
-8,184
| -27% | -$40.3K |
|
163
B2Gold
BTG
$5.52B
| $110K | 0.13% |
+38,554
| New | +$110K |
|
164
Amcor
AMCR
$19.1B
| $108K | 0.13% |
+11,124
| New | +$108K |
|
|
NFGC
165
New Found Gold
NFGC
$437M
| $107K | 0.13% |
+88,594
| New | +$107K |
|
166
Emergent Biosolutions
EBS
$404M
| $106K | 0.13% |
+21,841
| New | +$106K |
|
167
Gossamer Bio
GOSS
$668M
| $106K | 0.13% |
96,113
-127,657
| -57% | -$140K |
|
|
INV
168
Innventure, Inc. Common Stock
INV
$308M
| $103K | 0.12% |
+13,331
| New | +$103K |
|
169
Viatris
VTRS
$12.2B
| $99.1K | 0.12% |
+11,379
| New | +$99.1K |
|
170
Xperi
XPER
$284M
| $98.7K | 0.12% |
12,785
-18,107
| -59% | -$140K |
|
171
Amplify Energy
AMPY
$155M
| $98.1K | 0.12% |
26,237
-66,847
| -72% | -$250K |
|
172
Bitdeer Technologies
BTDR
$2.64B
| $96.6K | 0.11% |
+10,940
| New | +$96.6K |
|
|
NKGN
173
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $93.3K | 0.11% |
518,134
| – | – |
|
174
Core Scientific
CORZ
$4.16B
| $92.4K | 0.11% |
+12,762
| New | +$92.4K |
|
175
Abeona Therapeutics
ABEO
$353M
| $89.3K | 0.11% |
+18,754
| New | +$89.3K |
|